← Leaderboards
Ju-Seog Lee
University Of Tx Md Anderson Can Ctr
$2,908,298
Attributed
$2,908,298
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $366K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,908,298 · 2
By mechanism
R01$2,908,298 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ivan P Gorlov$3,179,655
- Kelly K Hunt$5,274,757
- Wendy A Woodward$3,444,065
- Christopher Chad Quarles$12,985,497
- John F De Groot$2,436,888
Others in their field
Top investigators on “Gene Expression Profiling”
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Eric S Lander · Whitehead Institute For Biomedical Res$65,664,403
- Nenad Sestan · Yale University$60,220,019
- Stacey Gabriel · Broad Institute, Inc.$55,559,004
- Ed Lein · Allen Institute$55,482,178
- Richard K. Wilson · Washington University$48,782,267
Research focus
Gene Expression ProfilingVirulentCancer TypeMalignant NeoplasmsCancer CenterPublic Health RelevancePrognosticBaseAngiogenesis InhibitorsDesignDisease PathwayAccountingAutomobile DrivingDisease ProgressionApoptosisCell PhysiologyCessation Of LifeAntisense OligonucleotidesCancer EtiologyAblationCancer TherapyCell GrowthAngiogenesisAftercare
Grant awards (9)
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION$339,827
R01 · FY2024 · CA · contact PI
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION$350,558
R01 · FY2023 · CA · contact PI
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION$350,558
R01 · FY2022 · CA · contact PI
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION$364,827
R01 · FY2021 · CA · contact PI
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION$365,994
R01 · FY2020 · CA · contact PI
DEVELOPMENT AND VALIDATION OF PROGNOSTIC MODEL FOR GASTRIC CANCER$269,041
R01 · FY2013 · CA · contact PI
DEVELOPMENT AND VALIDATION OF PROGNOSTIC MODEL FOR GASTRIC CANCER$286,214
R01 · FY2012 · CA · contact PI
DEVELOPMENT AND VALIDATION OF PROGNOSTIC MODEL FOR GASTRIC CANCER$286,214
R01 · FY2011 · CA · contact PI
DEVELOPMENT AND VALIDATION OF PROGNOSTIC MODEL FOR GASTRIC CANCER$295,065
R01 · FY2010 · CA · contact PI